A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has highlighted the need for broad-spectrum antivirals against coronaviruses (CoVs). Here, pheophorbide a (Pba) was identified as a highly active antiviral molecule against human CoV-229E after bioguided fractionation of plant extracts.
Article activity feed
-
-
SciScore for 10.1101/2021.07.09.451770: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: Plant collection and extraction: The fifteen plants were collected in the Bafing region (North-West Côte d’Ivoire Sex as a biological variable not detected. Randomization For each coverslip, a series of six 8-bit images of randomly picked areas were recorded. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Polyclonal rabbit anti-SARS-CoV-2 nucleocapsid antibodies were from Novus. anti-SARS-CoV-2 nucleocapsid antibodies were from Novus .suggested: NoneCyanine 3-conjugated goat anti-mouse IgG and HRP-labeled goat-anti rabbit IgG antibodies were from Jackson Immunoresearch. Cyanine 3-conjugated goat …SciScore for 10.1101/2021.07.09.451770: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics Field Sample Permit: Plant collection and extraction: The fifteen plants were collected in the Bafing region (North-West Côte d’Ivoire Sex as a biological variable not detected. Randomization For each coverslip, a series of six 8-bit images of randomly picked areas were recorded. Blinding not detected. Power Analysis not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Polyclonal rabbit anti-SARS-CoV-2 nucleocapsid antibodies were from Novus. anti-SARS-CoV-2 nucleocapsid antibodies were from Novus .suggested: NoneCyanine 3-conjugated goat anti-mouse IgG and HRP-labeled goat-anti rabbit IgG antibodies were from Jackson Immunoresearch. Cyanine 3-conjugated goat anti-mouse IgGsuggested: Noneanti-mouse IgGsuggested: NoneMembranes were incubated overnight at 4°C with polyclonal rabbit anti-SARS-CoV-2 nucleocapsid antibodies in 5% (w/v) non-fat dry milk in PBS with 0.1% (v/v) Tween-20. anti-SARS-CoV-2 nucleocapsidsuggested: NoneAfter being washed 3 times with PBS with 0.1% (v/v) Tween-20, membranes were incubated for 1 h at RT with HRP-labeled goat-anti rabbit IgG antibodies, after which membranes were washed 3 times. rabbit IgGsuggested: NoneThey were then rinsed with PBS and processed for immunofluorescence as previously described (56) using primary mouse antibodies specific to HCV E1 (for both HCV and SINV), YFV E, or dsRNA (for CVB4), followed by a cyanine-3-conjugated goat anti-mouse IgG secondary antibody for the detection of infected cells. CVB4suggested: NoneTwenty-four hours p.t., cells were fixed with 3% paraformaldehyde in PBS for 20 min at RT and syncytia were visualized by immunofluorescence, by incubating the cells with a monoclonal anti-SARS-CoV-2-spike antibody in 10% normal goat serum, followed by incubation with Cyanine-3-conjugated goat anti-mouse IgG antibodies. anti-SARS-CoV-2-spikesuggested: NoneExperimental Models: Cell Lines Sentences Resources Cells and culture conditions: Huh-7, Vero-81 (ATCC number CCL-81) and Vero-E6 were grown in DMEM with glutaMAX-I and 10% FBS in an incubator at 37°C with 5% CO2. Huh-7suggested: NoneVero-E6suggested: NoneViruses: The following viral strains were used: HCoV-229E strain VR-740 (ATCC), and a recombinant HCoV-229E-Luc (kind gift of Pr. V. Thiel) (53); SARS-CoV-2 (isolate SARS-CoV-2/human/FRA/Lille_Vero-81-TMPRSS2/2020, NCBI MW575140) was propagated on Vero-81-TMPRSS2 cells. Vero-81-TMPRSS2suggested: NoneHCoV-229E titers: Huh-7 and Huh-7-TMPRSS2 cells seeded in 24-well plates were inoculated with HCoV-229E at a MOI of 0.5 in the presence of Pba at different concentrations for 1 h at 37°C. Huh-7-TMPRSS2suggested: NoneCell-cell fusion assay by transient expression of the SARS-CoV-2 spike protein: Vero-81 cells were seeded on coverslips in 24-wells 16 h before transfection. Vero-81suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Viruses: The following viral strains were used: HCoV-229E strain VR-740 (ATCC), and a recombinant HCoV-229E-Luc (kind gift of Pr. V. Thiel) (53); SARS-CoV-2 (isolate SARS-CoV-2/human/FRA/Lille_Vero-81-TMPRSS2/2020, NCBI MW575140) was propagated on Vero-81-TMPRSS2 cells. HCoV-229Esuggested: NoneRecombinant DNA Sentences Resources Cells were transfected with 250 ng of a pCDNA3.1(+ pCDNA3.1suggested: RRID:Addgene_79663)Software and Algorithms Sentences Resources Images were acquired on an Evos M5000 imaging system (Thermo Fisher Scientic) equipped with light cubes for DAPI, and RFP, and a 10× objective. Thermo Fisher Scienticsuggested: NoneInfected cells and nuclei were automatically counted using macros written in ImageJ. ImageJsuggested: (ImageJ, RRID:SCR_003070)Statistical analysis and IC50 and CC50 calculation: Values were graphed and IC50 calculated by non-linear regression curve fitting with variable slopes constraining the top to 100% and the bottom to 0%, using GraphPad PRISM software. GraphPad PRISMsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-